Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

D. Pauleit · Brain · 2005 · 637 citations

Medicine, Nuclear Medicine, Oncology +17

Radiolabeled amino acids: basic aspects and clinical applications in oncology.

PL Jager, Willem Vaalburg, Jan Pruim et al. · PubMed · 2001 · 556 citations

Medicine, Nuclear Medicine, Radiology +14

O -(2-[ 18 F]Fluoroethyl)- l -tyrosine and l -[methyl- 11 C]methionine uptake in brain tumours: initial results of a comparative study

Wolfgang Weber, H.-J. Wester, Michael Herz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 389 citations

Medicine, Oncology, Pharmacology +12

Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.

S. W. Mayer, Michael Herz, Hans‐Jürgen Wester et al. · PubMed · 1999 · 239 citations

Engineering, Biochemistry, Pharmacokinetics +14

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours

Matthias Weckesser, Karl‐Josef Langen, Christian Rickert et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 192 citations

Medicine, Nuclear Medicine, Oncology +13